{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib4j6k4iroidyhwmofar6z43b6sdmk4jfg72v5thk6ppaqyjzasi4",
    "uri": "at://did:plc:nnaxwirbqywidimahadp42bj/app.bsky.feed.post/3mlbasuobmz62"
  },
  "path": "/silence-therapeutics-highlights-recent-business-achievements-and-reports-first-quarter-2026-financial-results/",
  "publishedAt": "2026-05-07T12:08:15.000Z",
  "site": "https://www.cityam.com",
  "tags": [
    "Conference",
    "Earnings"
  ],
  "textContent": "Phase 2 SANRECO trial of divesiran, a first-in-class siRNA for polycythemia vera (PV), on-track for topline results in August 2026",
  "title": "Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results"
}